top of page
top.png
Picture1.png
Picture1.png

The Vasileva Lab

Hijacked Development in Pediatric Cancers

Center for Cancer and Immunology Research

Children's National Hospital

Washington, DC

Cancer origin

Understanding how oncogenic fusions rewire cell identity and alter developmental trajectories.

Tumor initiation

Leveraging zebrafish genetic models of pediatric cancer to study tumor initiation and establishment in a complex developmental landscape.

Cancer-niche 

communication

Defining the role of proteoglycans in orchestrating tumor–microenvironment interactions in pediatric cancer.

Developmental vulnerabilities

Identifying lineage-specific vulnerabilities of cancer cells to advance targeted therapeutic approaches.

Picture1.png

Our lab in the Center for Cancer and Immunology Research (CCIR) with the support of the Brain Tumor Institute (BTI)  at Children's National Hospital explores the developmental origins of childhood cancer, focusing on the molecular and cellular mechanisms that drive tumor initiation and progression. We develop and utilize genetic zebrafish models of pediatric cancer (New Approach Methodolog, NAM) to investigate how healthy cells are transformed into cancer cells in vivo, how tumor cells hijack developmental signaling pathways for cell transformation and tumor establishment. Ultimately, we aim to leverage these insights to inform preventive strategies and develop new therapeutic approaches.

Presentation1_edited.jpg

Zebrafish Development

 

We are also actively recruiting motivated scientists at multiple levels, including postdoctoral fellows and research technicians. If you are passionate about pediatric cancer research, developmental biology, zebrafish models, or translational science, we would love to hear from you!

 

Our team in the Center for Cancer and Immunology Research

at Children's National Hospital 

1663368126232.jpeg
Picture1.png
photo_2026-05-05 15.17.55.jpeg

Our latest research papers and findings.

Cell Reports.png
elife.png

Luck et al., 2026

Vasileva et al., 2025

Vasileva et al., 2022

We'd love to hear from you regarding our research or collaborations.

bottom of page